PMC:6707402 / 20162-20531 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6707402","sourcedb":"PMC","sourceid":"6707402","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6707402","text":"†Incidences of the adverse reactions have been calculated for all the individual studies. (min%–max%) are the lowest and highest observed incidence of an adverse reaction observed in the group of studies included.\n‡ Transdermal application only.\n§ One study administered DMSO through intraarticular injection [ 38].\n¶ DMSO was administered intravenously in all studies.","divisions":[{"label":"p","span":{"begin":0,"end":214}},{"label":"p","span":{"begin":214,"end":245}},{"label":"p","span":{"begin":246,"end":315}}],"tracks":[{"project":"MyTest","denotations":[{"id":"31489176-7257033-30448502","span":{"begin":311,"end":313},"obj":"7257033"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"attributes":[{"subj":"31489176-7257033-30448502","pred":"source","obj":"MyTest"}]},{"project":"2_test","denotations":[{"id":"31489176-7257033-30448502","span":{"begin":311,"end":313},"obj":"7257033"}],"attributes":[{"subj":"31489176-7257033-30448502","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"MyTest","color":"#ec93c9","default":true},{"id":"2_test","color":"#93e3ec"}]}]}}